Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes

被引：13
|
作者：
Filippatos, Gerasimos [1 ]
Anker, Stefan D. [2 ,3 ]
Agarwal, Rajiv [4 ]
Pitt, Bertram [5 ]
Rossing, Peter [6 ,7 ]
Ruilope, Luis M. [8 ,9 ,10 ]
Kolkhof, Peter [11 ]
Schloemer, Patrick [12 ]
Tornus, Ingo [13 ]
Joseph, Amer [13 ]
Bakris, George L. [14 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Sch Med, Dept Cardiol, Athens, Greece
[2] Charite, Dept Cardiol CVK, Berlin, Germany
[3] Charite, Berlin Inst Hlth Ctr Regenerat Therapies, German Ctr Cardiovasc Rsch Partner Site Berlin, Berlin, Germany
[4] Indiana Univ, Richard L Roudebush VA Med Ctr, Indianapolis, IN 46204 USA
[5] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48104 USA
[6] Steno Diabet Ctr Copenhagen, Dept Clin Med, Copenhagen, Denmark
[7] Univ Copenhagen, Copenhagen, Denmark
[8] Hosp 12 Octubre, Inst Rsch imas12, CIBER CV, Cardiorenal Translat Lab & Hypertens Unit, Madrid, Spain
[9] Hosp 12 Octubre, Inst Rsch imas12, Fac Sport Sci, Madrid, Spain
[10] European Univ Madrid, Madrid, Spain
[11] Bayer AG, Preclin Rsch Cardiovasc, Rsch & Dev, Berlin, Germany
[12] Bayer AG, Rsch & Dev Stat & Data Insights, Berlin, Germany
[13] Bayer AG, Cardiol & Nephrol Clin Dev, Berlin, Germany
[14] Univ Chicago Med, Med, Chicago, IL USA
来源：
CIRCULATION | 2020年 / 142卷 / 24期
关键词：
Diabetes Mellitus; Aldosterone; Kidney; Mortality; Clinical trials;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
18631
引用
收藏
页码：E470 / E470
页数：1
相关论文
共 50 条
  • [31] Single institution prescribing pattern of finerenone in patients with type 2 diabetes and/or chronic kidney disease in the USA
    Zhang, Rong M.
    [J]. CLINICAL KIDNEY JOURNAL, 2023, 16 (09) : 1538 - 1539
  • [32] Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone
    Agarwal, Rajiv
    Anker, Stefan D.
    Bakris, George
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Ruilope, Luis
    Gebel, Martin
    Kolkhof, Peter
    Nowack, Christina
    Joseph, Amer
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (06) : 1014 - 1023
  • [33] Efficacy and safety of finerenone by age and sex subgroups in patients with chronic kidney disease and type 2 diabetes
    Bansal, S.
    Anker, S.
    Bakris, G.
    Filippatos, G.
    Rossing, P.
    Ruilope, L.
    Birne, R.
    Canziani, M.
    Farjat, A.
    Brinker, M.
    Pitt, B.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2023, 197
  • [34] Effect of finerenone on the incidence of hypokalemia in patients with type 2 diabetes and chronic kidney disease: A FIDELITY analysis
    Pitt, B.
    Agarwal, R.
    Anker, S.
    Bakris, G.
    Rossing, P.
    Ruilope, L.
    Herzog, C.
    Greenberg, B.
    Pecoits-Filho, R.
    Zannad, F.
    Lambelet, M.
    Lawatscheck, R.
    Scalise, A.
    Filippatos, G.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 415 - 415
  • [35] Long-term cardiorenal efficacy of finerenone in patients with chronic kidney disease and type 2 diabetes
    Qiu, Mei
    Zhao, Li-Min
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 11239 - 11241
  • [36] Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
    Wanner, Christoph
    Lachin, John M.
    Inzucchi, Silvio E.
    Fitchett, David
    Mattheus, Michaela
    George, Jyothis
    Woerle, Hans J.
    Broedl, Uli C.
    von Eynatten, Maximilian
    Zinman, Bernard
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    [J]. CIRCULATION, 2018, 137 (02) : 119 - 129
  • [37] Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes
    Agarwal, Rajiv
    Ruilope, Luis M.
    Ruiz-Hurtado, Gema
    Haller, Hermann
    Schmieder, Roland E.
    Anker, Stefan D.
    Filippatos, Gerasimos
    Pitt, Bertram
    Rossing, Peter
    Lambelet, Marc
    Nowack, Christina
    Kolkhof, Peter
    Joseph, Amer
    Bakris, George L.
    [J]. JOURNAL OF HYPERTENSION, 2023, 41 (02) : 295 - 302
  • [38] Cardiorenal Outcomes with Finerenone in Asian Patients with Chronic Kidney Disease and Type 2 Diabetes: A FIDELIO-DKD post hoc Analysis
    Koya, Daisuke
    Anker, Stefan D.
    Ruilope, Luis M.
    Rossing, Peter
    Liu, Zhihong
    Lee, Byung Wan
    Lee, Chien-Te
    Scott, Charlie
    Kolkhof, Peter
    Lawatscheck, Robert
    Wang, Lili
    Joseph, Amer
    Pitt, Bertram
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2023, 54 (9-10) : 370 - 378
  • [39] Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis
    Filippatos, Gerasimos
    Anker, Stefan D.
    August, Phyllis
    Coats, Andrew J. S.
    Januzzi, James L.
    Mankovsky, Boris
    Rossing, Peter
    Ruilope, Luis M.
    Pitt, Bertram
    Sarafidis, Pantelis
    Teerlink, John R.
    Kapelios, Chris J.
    Gebel, Martin
    Brinker, Meike
    Joseph, Amer
    Lage, Andrea
    Bakris, George
    Agarwal, Rajiv
    [J]. EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (02) : 183 - 191
  • [40] Pharmacotherapy considerations with finerenone in the treatment of chronic kidney disease associated with type 2 diabetes
    Ashjian, Emily
    Clarke, Megan
    Pogue, Kristen
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2023, 80 (23) : 1708 - 1721
12345